Systematic review of thiopurine methyltransferase genotype and enzymatic testing strategies

Therapeutic Drug Monitoring

Volumn 33, Issue 2, 2011, Pages 192-199

  Donnan, Jennifer R ^a,b   Ungar, Wendy J ^a,c   Mathews, Maria ^d   Rahman, Proton ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b Newfoundland and Labrador Centre for Health Information   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

pharmacogenetics; sensitivity and specificity; systematic review; thiopurine methyltransferase

Indexed keywords

6 METHYLTHIOGUANINE; AZATHIOPRINE; DRUG METABOLITE; MERCAPTOPURINE; METHYLMERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE; TIOGUANINE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; DRUG METABOLISM; ENTERITIS; ENZYME ACTIVITY; ENZYME ASSAY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

ARTHRITIS, RHEUMATOID; CHILD; CLINICAL ENZYME TESTS; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKEMIA; METHYLTRANSFERASES; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY;

EID: 79953201846     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31820810cd     Document Type: Article

References (32)

1. Krynetski EY, Tai HL, Yates CR, et al. Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics. 1996;6:279-290. (Pubitemid 26288618)
2. McLeod HL, Krynetski EY, Relling MV, et al. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia. 2000;14:567-572. (Pubitemid 30195445)
3. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet. 1980;32:651-662. (Pubitemid 10061685)
4. Szumlanski CL, Honchel R, Scott MC, et al. Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes. Pharmacogenetics. 1992;2: 148-159.
5. Andersen JB, Szumlanski C, Weinshilboum RM, et al. Pharmacokinetics, dose adjustments, and 6-mercaptopurine/methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency. Acta Paediatr. 1998;87:108-111. (Pubitemid 28086619)
6. Lennard L. Clinical implications of thiopurine methyltransferase- optimization of drug dosage and potential drug interactions. Ther Drug Monit. 1998;20:527-531. (Pubitemid 28463444)
7. Yates CR, Krynetski EY, Loennechen T, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med. 1997;126:608-614. (Pubitemid 27172187)
8. Alves S, Amorim A, Ferreira F, et al. Influence of the variable number of tandem repeats located in the promoter region of the thiopurine methyltransferase gene on enzymatic activity. Clin Pharmacol Ther. 2001;70:165-174. (Pubitemid 32777769)
9. Anglicheau D, Sanquer S, Loriot MA, et al. Thiopurine methyltransferase activity: New conditions for reversed-phase high-performance liquid chromatographic assay without extraction and genotypic-phenotypic correlation. J Chromatogr. 2002;773:119-127. (Pubitemid 34595383)
10. Indjova D, Atanasova S, Shipkova M, et al. Phenotypic and genotypic analysis of thiopurine s-methyltransferase polymorphism in the bulgarian population. Ther Drug Monit. 2003;25:631-636. (Pubitemid 37238898)
11. Larovere LE, de Kremer RD, Lambooy LH, et al. Genetic polymorphism of thiopurine S-methyltransferase in Argentina. Ann Clin Biochem. 2003; 40(Pt 4):388-393. (Pubitemid 36819557)
12. Wusk B, Kullak-Ublick GA, Rammert C, et al. Thiopurine S-methyltransferase polymorphisms: efficient screening method for patients considering taking thiopurine drugs. Eur J Clin Pharmacol. 2004;60:5-10. (Pubitemid 38476965)
13. Winter JW, Gaffney D, Shapiro D, et al. Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with in- flammatory bowel disease. Aliment Pharmacol Ther. 2007;25:1069-1077. (Pubitemid 46587697)
14. Kham SK, Soh CK, Liu TC, et al. Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore. Eur J Clin Pharmacol. 2008;64:373-379.
15. Marinaki AM, Arenas M, Khan ZH, et al. Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype in British Asians and Caucasians. Pharmacogenetics. 2003;13:97-105. (Pubitemid 36259589)
16. McPherson MJ, Moller SG. PCR. 2nd ed. New York, NY: Taylor and Francis Group; 2006.
17. Nasedkina TV, Fedorova OE, Glotov AS, et al. Rapid genotyping of common deficient thiopurine S-methyltransferase alleles using the DNAmicrochip technique. Eur J Hum Genet. 2006;14:991-998. (Pubitemid 44275832)
18. Khan KS, Kunz R, Kleijnen J, et al, eds. Systematic Reviews to Support Evidence-Based Medicine: How to Review and Apply Findings of Healthcare Research. London, United Kingdom: Royal Society of Medicine Press; 2007.
19. Center for Drug Evaluation and Research. Available at: http://www.fda. gov/Drugs/default.htm. Accessed August 17, 2010.
20. Public Health Resource Unit, National Health Service. Appraisal tools: diagnostic test studies. Available at: http://www.sph.nhs.uk/sph-files/ Diagnostic%20Tests%2012%20Questions.pdf. England: Public Health Resource Unit; 2006. Accessed October 22, 2010.
21. Hon YY, Fessing MY, Pui CH, et al. Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum Mol Genet. 1999; 8:371-376. (Pubitemid 29054281)
22. Loennechen T, Utsi E, Hartz I, et al. Detection of one single mutation predicts thiopurine S-methyltransferase activity in a population of Saami in northern Norway. Clinical Pharmacol Ther. 2001;70:183-188. (Pubitemid 32777771)
23. Lu Y, Kham SK, Tan PL, et al. Arrayed primer extension: a robust and reliable genotyping platform for the diagnosis of single gene disorders: beta-thalassemia and thiopurine methyltransferase deficiency. Genet Test. 2005;9:212-219. (Pubitemid 41507753)
24. Reis M, Santoro A, Suarez-Kurtz G. Thiopurine methyltransferase phenotypes and genotypes in Brazilians. Pharmacogenetics. 2003;13:371-373. (Pubitemid 36724531)
25. Rossi AM, Bianchi M, Guarnieri C, et al. Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects. Eur J Clin Pharmacol. 2001;57:51-54. (Pubitemid 32391413)
26. Schaeffeler E, Fischer C, Brockmeier D, et al. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics. 2004;14:407-417. (Pubitemid 38971231)
27. Schaeffeler E, Lang T, Zanger UM, et al. High-throughput genotyping of thiopurine S-methyltransferase by denaturing HPLC. Clinical Chem. 2001;47:548-555. (Pubitemid 32222472)
28. Spire-Vayron de la Moureyre C, Debuysere H, Sabbagh N, et al. Detection of known and newmutations in the thiopurine S-methyltransferase gene by singlestrand conformation polymorphism analysis. Hum Mutat. 1998;12:177-185. (Pubitemid 28384589)
29. Winter J, Walker A, Shapiro D, et al. Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20:593-599. (Pubitemid 39279046)
30. Bachmann LM, Puhan MA, ter Riet G, et al. Sample sizes of studies on diagnostic accuracy: literature survey. BMJ. 2006;332:1127-1129. (Pubitemid 44480877)
31. Hopewell S, Loudon K, Clarke MJ, et al. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev. 2009(1):MR000006.
32. Tricco AC, Tetzlaff J, Sampson M, et al. Few systematic reviews exist documenting the extent of bias: a systematic review. J Clin Epidemiol. 2008; 61:422-434. (Pubitemid 351446187)